Condition
Plastic Bronchitis
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Completed2
Recruiting1
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07131293Recruiting
European Registry Study on Lymphatic Interventions
NCT02315898Phase 2CompletedPrimary
Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis
NCT04163653Completed
Lymphatic Morphology of Fontan Patients
NCT01663948TerminatedPrimary
International Plastic Bronchitis Registry
NCT03942926Phase 2UnknownPrimary
The Efficacy and Safety of Sirolimus for Plastic Bronchitis
Showing all 5 trials